Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease

Biochemistry and Cell Biology

Volumn 82, Issue 1, 2004, Pages 129-144

  Quest, Andrew F G ^a   Leyton, Lisette ^a   Párraga, Mario ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Cancer; Caveolae; Caveolins; Disease; Membrane microdomains; Rafts; Signal transduction

Indexed keywords

CELLS; CHOLESTEROL; DATA REDUCTION; DISEASES; LIPIDS; PROTEINS;

CELLULAR SIGNALING; CELLULAR TRANSPORT; MOLECULAR MARKERS;

BIOCHEMISTRY;

CAVEOLIN; CAVEOLIN 1; CAVEOLIN 3; DETERGENT; ISOENZYME; MEMBRANE LIPID; MITOGEN ACTIVATED PROTEIN KINASE; SPHINGOLIPID; STRUCTURAL PROTEIN;

AMINO ACID SEQUENCE; CARCINOGENESIS; CAVEOLA; CELL SURFACE; CELL VACUOLE; CELLULAR DISTRIBUTION; CHOLESTEROL TRANSPORT; CYTOSKELETON; DISEASE COURSE; ENDOCYTOSIS; GENE CONTROL; GENE EXPRESSION; GENE STRUCTURE; GENETIC VARIABILITY; INTRACELLULAR TRANSPORT; MOLECULAR CLONING; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL TRANSFORMATION;

ANIMALS; BIOLOGICAL TRANSPORT; CAVEOLAE; CAVEOLIN 1; CAVEOLINS; CELL LINE, TUMOR; HUMANS; INFECTION; MEMBRANE MICRODOMAINS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 2342566404     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o03-071     Document Type: Review

References (146)

1. Anderson, R.G. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67: 199-225.
2. Anderson, R.G., and Jacobson, K. 2002. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science (Wash., D.C.), 296: 1821-1825.
3. Anderson, R.G., Kamen, B.A., Rothberg, K.G., and Lacey, S.W. 1992. Potocytosis: sequestration and transport of small molecules by caveolae. Science (Wash., D.C.), 255: 410-411.
4. Bender, F.C., Reymond, M.A., Bron, C., and Quest, A.F. 2000. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res. 60: 5870-5878.
5. Bender, F., Montoya, M., Monardes, V., Leyton, L., and Quest, A.F. 2002. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol. Res. 35: 151-167.
6. Bist, A., Fielding, P.E., and Fielding, C.J. 1997. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc. Natl. Acad. Sci. U.S.A. 94: 10 693 - 10 698.
7. Brown, D.A., and London, E. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14: 111-136.
8. Brown, D.A., and Rose, J.K. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell, 68: 533-544.
9. Campbell, L., Laidler, P., Watson, R.E., Kirby, B., Griffiths, C.E., and Gumbleton, M. 2002. Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis. Br. J. Dermatol. 147: 701-709.
10. Cao, H., Courchesne, W.E., and Mastick, C.C. 2002. A phosphotyrosine- dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C- terminal Src kinase. J. Biol. Chem. 277: 8771-8774.
11. Capozza, F., Williams, T.M., Schubert, W., McClain, S., Bouzahzah, B., Sotgia, F., and Lisanti, M.P. 2003. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol. 162: 2029-2039.
12. Chang, W.J., Rothberg, K.G., Kamen, B.A., and Anderson, R.G. 1992. Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J. Cell Biol. 118: 63-69.
13. de Marco, M.C., Kremer, L., Albar, J.P., Martinez-Menarguez, J.A., Ballesta, J., Garcia-Lopez, M.A., Marazuela, M., Puertollano, R., and Alonso, M.A. 2001. BENE, a novel raft-associated protein of the MAL proteolipid family, interacts with caveolin-1 in human endothelial-like ECV304 cells. J. Biol. Chem. 276: 23 009 - 23 017.
14. Dessy, C., Kelly, R.A., Balligand, J.L., and Feron, O. 2000. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J. 19: 4272-4280.
15. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F.C., Schedl, A., Haller, H., and Kurzchalia, T.V. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (Wash., D.C.), 293: 2449-2452.
16. Dupree, P., Parton, R.G., Raposo, G., Kurzchalia, T.V., and Simons, K. 1993. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 12: 1597-1605.
17. Engelman, J.A., Wykoff, C.C., Yasuhara, S., Song, K.S., Okamoto, T., and Lisanti, M.P. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272: 16 374 - 16 381.
18. Engelman, J.A., Chu, C., Lin, A., Jo, H., Ikezu, T., Okamoto, T., Kohtz, D.S., and Lisanti, M.P. 1998. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428: 205-211.
19. Engelman, J.A., Zhang, X.L., Razani, B., Pestell, R.G., and Lisanti, M.P. 1999. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J. Biol. Chem. 274: 32 333 - 32 341.
20. Felley-Bosco, E., Bender, F.C., Courjault-Gautier, F., Bron, C., and Quest, A.F. 2000. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 97: 14 334 - 14 339.
21. Felley-Bosco, E., Bender, F.C., and Quest, A.F. 2002. Caveolin-1-mediated post-transcriptional regulation of inducible nitric oxide synthase in human colon carcinoma cells. Biol. Res. 35: 169-176.
22. Fernandez, I., Ying, Y., Albanesi, J., and Anderson, R.G. 2002. Mechanism of caveolin filament assembly. Proc. Natl. Acad. Sci. U.S.A. 99: 11 193 - 11 198.
23. Fiedler, K., Parton, R.G., Kellner, R., Etzold, T., and Simons, K. 1994. VIP36, a novel component of glycolipid rafts and exocytic carrier vesicles in epithelial cells. EMBO J. 13: 1729-1740.
24. Fielding, C.J., and Fielding, P.E. 2001. Caveolae and intracellular trafficking of cholesterol. Adv. Drug Delivery Rev. 49: 251-264.
25. Fielding, C.J., and Fielding, P.E. 2003. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim. Biophys. Acta, 1610: 219-228.
26. Fielding, C.J., Bist, A., and Fielding, P.E. 1997. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc. Natl. Acad. Sci. U.S.A. 94: 3753-3758.
27. Fiucci, G., Ravid, D., Reich, R., and Liscovitch, M. 2002. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene, 21: 2365-2375.
28. Fra, A.M., Williamson, E., Simons, K., and Parton, R.G. 1995. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. U.S.A. 92: 8655-8659.
29. Frank, P.G., Galbiati, F., Volonte, D., Razani, B., Cohen, D.E., Marcel, Y.L., and Lisanti, M.P. 2001. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am. J. Physiol. Cell Physiol. 280: C1204-C1214.
30. Fujimoto, T. 1993. Calcium pump of the plasma membrane is localized in caveolae. J. Cell Biol. 120: 1147-1157.
31. Fujimoto, T., Kogo, H., Nomura, R., and Une, T. 2000. Isoforms of caveolin-1 and caveolar structure. J. Cell Sci. 113(Pt. 19): 3509-3517.
32. Galbiati, F., Volonte, D., Engelman, J.A., Watanabe, G., Burk, R., Pestell, R.G., and Lisanti, M.P. 1998. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17: 6633-6648.
33. Galbiati, F., Volonte, D., Brown, A.M.C., Weinstein, D.E., Ben-Ze'ev, A., Pestell, R.G., and Lisanti, M.P. 2000. Caveolin-1 expression inhibits Wnt/β-Catenin/Lef-1 signaling by recruiting β-catenin to caveolae membrane domains. J. Biol. Chem. 275: 23 368 - 23 377.
34. Galbiati, F., Volonte, D., Liu, J., Capozza, F., Frank, P.G., Zhu, L., Pestell, R.G., and Lisanti, M.P. 2001. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol. Biol. Cell, 12: 2229-2244.
35. Glenney, J.R., Jr. 1989. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J. Biol. Chem. 264: 20 163 - 20 166.
36. Glenney, J.R., Jr., and Soppet, D. 1992. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 89: 10 517 - 10 521.
37. Glenney, J.R., Jr., and Zokas, L. 1989. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J. Cell Biol. 108: 2401-2408.
38. Hara-Kuge, S., Ohkura, T., Ideo, H., Shimada, O., Atsumi, S., and Yamashita, K. 2002. Involvement of VIP36 in intracellular transport and secretion of glycoproteins in polarized Madin-Darby canine kidney (MDCK) cells. J. Biol. Chem. 277: 16 332 - 16 339.
39. Harder, T., and Kuhn, M. 2000. Selective accumulation of raft-associated membrane protein LAT in T cell receptor signaling assemblies. J. Cell Biol. 151: 199-208.
40. Hayashi, K., Matsuda, S., Machida, K., Yamamoto, T., Fukuda, Y., Nimura, Y., Hayakawa, T., and Hamaguchi, M. 2001. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res. 61: 2361-2364.
41. Henley, J.R., Krueger, E.W., Oswald, B.J., and McNiven, M.A. 1998. Dynamin-mediated internalization of caveolae. J. Cell Biol. 141: 85-99.
42. Ho, C.-C., Huang, P.-H., Huang, H.-Y., Chen, Y.-H., Yang, P.-C., and Hsu, S.-M. 2002. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am. J. Pathol. 161: 1647-1656.
43. Hulit, J., Bash, T., Fu, M., Galbiati, F., Albanese, C., Sage, D.R., Schlegel, A., Zhurinsky, J., Shtutman, M., Ben-Ze'ev, A., Lisanti, M.P., and Pestell, R.G. 2000. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J. Biol. Chem. 275: 21 203 - 21 209.
44. Ikonen, E., and Parton, R.G. 2000. Caveolins and cellular cholesterol balance. Traffic, 1: 212-217.
45. Ishikawa, H. 1968. Formation of elaborate networks of T-system tubules in cultured skeletal muscle with special reference to the T-system formation. J. Cell Biol. 87: 51-66.
46. Isshiki, M., and Anderson, R.G. 1999. Calcium signal transduction from caveolae. Cell Calcium, 26: 201-208.
47. Isshiki, M., Ying, Y.S., Fujita, T., and Anderson, R.G. 2002a. A molecular sensor detects signal transduction from caveolae in living cells. J. Biol. Chem. 277: 43 389 - 43 398.
48. Isshiki, M., Ando, J., Yamamoto, K., Fujita, T., Ying, Y., and Anderson, R.G. 2002b. Sites of Ca(2+) wave initiation move with caveolae to the trailing edge of migrating cells. J. Cell Sci. 115: 475-484.
49. Kimura, A., Mora, S., Shigematsu, S., Pessin, J.E., and Saltiel, A.R. 2002. The insulin receptor catalyzes the tyrosine phosphorylation of caveolin 1. J. Biol. Chem. 277: 30 153 - 30 158.
50. Kogo, H., and Fujimoto, T. 2000a. Caveolin-1 isoforms are encoded by distinct mRNAs. Identification of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett. 465: 119-123.
51. Kogo, H., and Fujimoto, T. 2000b. Concentration of caveolin-1 in the cleavage furrow as revealed by time-lapse analysis. Biochem. Biophys. Res. Commun. 268: 82-87.
52. Koleske, A.J., Baltimore, D., and Lisanti, M.P. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. U.S.A. 92: 1381-1385.
53. Kurzchalia, T.V., Dupree, P., Parton, R.G., Kellner, R., Virta, H., Lehnert, M., and Simons, K. 1992. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell Biol. 118: 1003-1014.
54. Lahtinen, U., Honsho, M., Parton, R.G., Simons, K., and Verkade, P. 2003. Involvement of caveolin-2 in caveolar biogenesis in MDCK cells. FEBS Lett. 538: 85-88.
55. Lai, E.C. 2003. Lipid rafts make for slippery platforms. J. Cell Biol. 162: 365-370.
56. Lamaze, C., Dujeancourt, A., Baba, T., Lo, C.G., Benmerah, A., and Dautry-Varsat, A. 2001. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell, 7: 661-671.
57. Lang, D.M., Lommel, S., Jung, M., Ankerhold, R., Petrausch, B., Laessing, U., Wiechers, M.F., Plattner, H., and Stuermer, C.A. 1998. Identification of reggie-1 and reggie-2 as plasma membrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J. Neurobiol. 37: 502-523.
58. Lavie, Y., and Liscovitch, M. 2000. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences. Glycoconj. J. 17: 253-259.
59. Lavie, Y., Fiucci, G., and Liscovitch, M. 1998. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273: 32 380 - 32 383.
60. Le, P.U., and Nabi, I.R. 2003. Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J. Cell Sci. 116: 1059-1071.
61. Le, P.U., Guay, G., Altschuler, Y., and Nabi, I.R. 2002. Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. J. Biol. Chem. 277: 3371-3379.
62. Lee, H., Volmte, D., Galbiati, F., Iyengar, P., Lublin, D.M., Bregman, D.B., Wilson, M.T., Campos-González, R., Bouzahzah, B., Pestell, R.G., Scherer, P.E., and Lisanti, M.P. 2000. Constitutive and growth-factor regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-src/cav-1/Grb7 signaling cassette. Mol. Endocrinol. 14: 1750-1775.
63. Lee, H., Woodman, S.E., Engelman, J.A., Volonte, D., Galbiati, F., Kaufman, H.L., Lublin, D.M., and Lisanti, M.P. 2001. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase. J. Biol. Chem. 276: 35 150 - 35 158.
64. Lee, H., Park, D.S., Razani, B., Russell, R.G., Pestell, R.G., and Lisanti, M.P. 2002. Caveolin-1 mutations (P132L and Null) and the pathogenesis of breast cancer. Caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am. J. Pathol. 161: 1357-1369.
65. Lee, S.W., Reimer, C.L., Oh, P., Campbell, D.B., and Schnitzer, J.E. 1998. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene, 16: 1391-1397.
66. Leo, A., Wienands, J., Baier, G., Horejsi, V., and Schraven, B. 2002. Adapters in lymphocyte signaling. J. Clin. Invest. 109: 301-309.
67. Leyton, L., Quest, A.F., and Bron, C. 1999. Thy-1/CD3 coengagement promotes TCR signaling and enhances particularly tyrosine phosphorylation of the raft molecule LAT. Mol. Immunol. 36: 755-768.
68. Li, L., Yang, G., Ebara, S., Satoh, T., Nasu, Y., Timme, T.L., Ren, C., Wang, J., Tahir, S.A., and Thompson, T.C. 2001. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res. 61: 4386-4392.
69. Li, S., Song, K.S., Koh, S.S., Kikuchi, A., and Lisanti, M.P. 1996. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis. J. Biol. Chem. 271: 28 647 - 28 654.
70. Li, W.P., Liu, P., Pilcher, B.K., and Anderson, R.G. 2001. Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J. Cell Sci. 114: 1397-1408.
71. Lipardi, C., Mora, R., Colomer, V., Paladino, S., Nitsch, L., Rodriguez-Boulan, E., and Zurzolo, C. 1998. Caveolin transfection results in caveolae formation but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells. J. Cell Biol. 140: 617-626.
72. Lisanti, M.P., Scherer, P.E., Vidugiriene, J., Tang, Z., Hermanowski-Vosatka, A., Tu, Y.H., Cook, R.F., and Sargiacomo, M. 1994. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126: 111-126.
73. Liu, J., Oh, P., Horner, T., Rogers, R.A., and Schnitzer, J.E. 1997. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J. Biol. Chem. 272: 7211-7222.
74. Liu, J., Razani, B., Tang, S., Terman, B.I., Ware, J.A., and Lisanti, M.P. 1999. Angiogenesis activators and inhibitors differentially regulate caveolin- 1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor- induced down-regulation of caveolin-1. J. Biol. Chem. 274: 15 781 - 15 785.
75. Liu, J., Lee, P., Galbiati, F., Kitsis, R.N., and Lisanti, M.P. 2001. Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. Am. J. Physiol. Cell Physiol. 280: C823-C835.
76. Liu, J., Wang, X.B., Park, D.S., and Lisanti, M.P. 2002. Caveolin-1 expression enhances endothelial capillary tubule formation. J. Biol. Chem. 277: 10 661 - 10 668.
77. Liu, P., Li, W.P., Machleidt, T., and Anderson, R.G. 1999. Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells. Nat. Cell Biol. 1: 369-375.
78. Liu, P., Rudick, M., and Anderson, R.G. 2002. Multiple functions of caveolin-1. J. Biol. Chem. 277: 41 295 - 41 298.
79. Machleidt, T., Li, W.P., Liu, P., and Anderson, R.G. 2000. Multiple domains in caveolin-1 control its intracellular traffic. J. Cell Biol. 148: 17-28.
80. Madore, N., Smith, K.L., Graham, C.H., Jen, A., Brady, K., Hall, S., and Morris, R. 1999. Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J. 18: 6917-6926.
81. Magee, T., Pirinen, N., Adler, J., Pagakis, S.N., and Parmryd, I. 2002. Lipid rafts: cell surface platforms for T cell signaling. Biol. Res. 35: 127-131.
82. Martin-Belmonte, F., Puertollano, R., Millan, J., and Alonso, M.A. 2000. The MAL proteolipid is necessary for the overall apical delivery of membrane proteins in the polarized epithelial Madin-Darby canine kidney and fischer rat thyroid cell lines. Mol. Biol. Cell, 11: 2033-2045.
83. Minetti, C., Bado, M., Broda, P., Sotgia, F., Bruno, C., Galbiati, F., Volonte, D., Lucania, G., Pavan, A., Bonilla, E., Lisanti, M.P., and Cordone, G. 2002. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am. J. Pathol. 160: 265-270.
84. Monier, S., Parton, R.G., Vogel, F., Behlke, J., Henske, A., and Kurzchalia, T.V. 1995. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell, 6: 911-927.
85. Morrow, I.C., Rea, S., Martin, S., Prior, I.A., Prohaska, R., Hancock, J.F., James, D.E., and Parton, R.G. 2002. Flotillin-1/reggie-2 traffics to surface raft domains via a novel golgi-independent pathway. Identification of a novel membrane targeting domain and a role for palmitoylation. J. Biol. Chem. 277: 48 834 - 48 841.
86. Mundy, D.I., Machleidt, T., Ting, Y.S., Anderson, R.G., and Bloom, G.S. 2002. Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J. Cell Sci. 115: 4327-4339.
87. Murata, M., Peranen, J., Schreiner, R., Wieland, F., Kurzchalia, T.V., and Simons, K. 1995. VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. U.S.A. 92: 10 339 - 10 343.
88. Nabi, I.R., and Le, P.U. 2003. Caveolae/raft-dependent endocytosis. J. Cell Biol. 161: 673-677.
89. Oh, P., McIntosh, D.P., and Schnitzer, J.E. 1998. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol. 141: 101-114.
90. Okamoto, T., Schlegel, A., Scherer, P.E., and Lisanti, M.P. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273: 5419-5422.
91. Palade, G.E. 1953. Fine structure of blood capillaries. J. Appl. Physiol. 24: 1424-1436.
92. Park, D.S., Lee, H., Riedel, C., Hulit, J., Scherer, P.E., Pestell, R.G., and Lisanti, M.P. 2001. Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. J. Biol. Chem. 276: 48 389 - 48 397.
93. Park, D.S., Woodman, S.E., Schubert, W., Cohen, A.W., Frank, P.G., Chandra, M., Shirani, J., Razani, B., Tang, B., Jelicks, L.A., Factor, S.M., Weiss, L.M., Tanowitz, H.B., and Lisanti, M.P. 2002. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am. J. Pathol. 160: 2207-2217.
94. Parton, R.G. 2003. Caveolae - from ultrastructure to molecular mechanisms. Nat. Rev. Mol. Cell Biol. 4: 162-167.
95. Parton, R.G., Joggerst, B., and Simons, K. 1994. Regulated internalization of caveolae. J. Cell Biol. 127: 1199-1215.
96. Patterson, S.I. 2002. Posttranslational protein S-palmitoylation and the compartmentalization of signaling molecules in neurons. Biol. Res. 35: 139-150.
97. Pelkmans, L., Kartenbeck, J., and Helenius, A. 2001. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3: 473-483.
98. Pelkmans, L., Puntener, D., and Helenius, A. 2002. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science (Wash., D.C.), 296: 535-539.
99. Pol, A., Luettetforst, R., Lindsay, M., Heino, S., Ikonen, E., and Parton, R.G. 2001. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol. J. Cell Biol. 152: 1057-1070.
100. Puri, V., Watanabe, R., Singh, R.D., Dominguez, M., Brown, J.C., Wheatley, C.L., Marks, D.L., and Pagano, R.E. 2001. Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J. Cell Biol. 154: 535-547.
101. Racine, C., Belanger, M., Hirabayashi, H., Boucher, M., Chakir, J., and Couet, J. 1999. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 255: 580-586.
102. Rajendran, L., Masilamani, M., Solomon, S., Tikkanen, R., Stuermer, C.A., Plattner, H., and Illges, H. 2003. Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 100: 8241-8246.
103. Razani, B., Engelman, J.A., Wang, X.B., Schubert, W., Zhang, X.L., Marks, C.B., Macaluso, F., Russell, R.G., Li, M., Pestell, R.G., Di Vizio, D., Hou, J.H., Knietz, B., Lagaud, G., Christ, G.J., Edelmann, W., and Lisanti, M.P. 2001. Caveolin-1 null mice are viable, but show evidence of hyper-proliferative and vascular abnormalities. J. Biol. Chem. 276: 38 121 - 38 138.
104. Razani, B., Woodman, S.E., and Lisanti, M.P. 2002a. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 54: 431-467.
105. Razani, B., Wang, X.B., Engelman, J.A., Battista, M., Lagaud, G., Zhang, X.L., Kneitz, B., Hou, H., Jr., Christ, G.J., Edelmann, W., and Lisanti, M.P. 2002b. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol. Cell. Biol. 22: 2329-2344.
106. Rothberg, K.G., Ying, Y.S., Kamen, B.A., and Anderson, R.G. 1990. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J. Cell Biol. 111: 2931-2938.
107. Rothberg, K.G., Heuser, J.E., Donzell, W.C., Ying, Y.S., Glenney, J.R., and Anderson, R.G. 1992. Caveolin, a protein component of caveolae membrane coats. Cell, 68: 673-682.
108. Roy, S., Luetterforst, R., Harding, A., Apolloni, A., Etheridge, M., Stang, E., Rolls, B., Hancock, J.F., and Parton, R.G. 1999. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat. Cell Biol. 1: 98-105.
109. Salzer, U., and Prohaska, R. 2001. Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood, 97: 1141-1143.
110. Scheiffele, P., Verkade, P., Fra, A.M., Virta, H., Simons, K., and Ikonen, E. 1998. Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J. Cell Biol. 140: 795-806.
111. Schlegel, A., and Lisanti, M.P. 2001. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine Growth Factor Rev. 12: 41-51.
112. Schnitzer, J.E., McIntosh, D.P., Dvorak, A.M., Liu, J., and Oh, P. 1995. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science (Wash., D.C.), 269: 1435-1439.
113. Schnitzer, J.E., Oh, P., and McIntosh, D.P. 1996. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science (Wash., D.C.), 274: 239-242.
114. Schubert, W., Frank, P.G., Woodman, S.E., Hyogo, H., Cohen, D.E., Chow, C.-W., and Lisanti, M.P. 2002. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores microvacular permeability in cav-1 null mice. J. Biol. Chem. 277: 40 091 - 40 098.
115. Shin, J.S., and Abraham, S.N. 2001. Cell biology. Caveolae - not just craters in the cellular landscape. Science (Wash., D.C.), 293: 1447-1448.
116. Simons, K., and Ikonen, E. 1997. Functional rafts in cell membranes. Nature (Lond.), 387: 569-572.
117. Simons, K., and Toomre, D. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1: 31-39.
118. Smart, E.J., Foster, D.C., Ying, Y.S., Kamen, B.A., and Anderson, R.G. 1994. Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae. J. Cell Biol. 124: 307-313.
119. Smart, E.J., Ying, Y.S., and Anderson, R.G. 1995. Hormonal regulation of caveolae internalization. J. Cell Biol. 131: 929-938.
120. Smart, E.J., Ying, Y., Donzell, W.C., and Anderson, R.G. 1996. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271: 29 427 - 29 435.
121. Smart, E.J., Graf, G.A., McNiven, M.A., Sessa, W.C., Engelman, J.A., Scherer, P.E., Okamoto, T., and Lisanti, M.P. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19: 7289-7304.
122. Sommera, C.L., Park, C.S., Lee, J., Feng, C., Fuller, C.L., Grinberg, A., Hildebrand, J.A., Lacana, E., Menon, R.K., Shores, E.W., Samelson, L.E., and Love, P.E. 2002. A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science (Wash., D.C.), 296: 2040-2043.
123. Sowa, G., Pypaert, M., Fulton, D., and Sessa, W.C. 2003. The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation. Proc. Natl. Acad. Sci. U.S.A. 100: 6511-6516.
124. Stahlhut, M., and van Deurs, B. 2000. Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol. Biol. Cell, 11: 325-337.
125. Stan, R. V. 2002. Structure and function of endothelial caveolae. Microsc. Res. Tech. 57: 350-364.
126. Stuermer, C.A., Lang, D.M., Kirsch, F., Wiechers, M., Deininger, S.O., and Plattner, H. 2001. Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2. Mol. Biol. Cell, 12: 3031-3045.
127. Tahir, S.A., Yang, G., Ebara, S., Timme, T.L., Satoh, T., Li, L., Goltsov, A., Ittmann, M., Morrisett, J.D., and Thompson, T.C. 2001. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res. 61: 3882-3885.
128. Tang, Z., Okamoto, T., Boontrakulpoontawee, P., Katada, T., Otsuka, A.J., and Lisanti, M.P. 1997. Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans. Implications for the molecular evolution of mammalian caveolin genes. J. Biol. Chem. 272: 2437-2445.
129. Tavernarakis, N., Driscoll, M., and Kyrpides, N.C. 1999. The SPFH domain: implicated in regulating targeted protein turnover in stomatins and other membrane-associated proteins. Trends Biochem. Sci. 24: 425-427.
130. Thomsen, P., Roepstorff, K., Stahlhut, M., and van Deurs, B. 2002. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell, 13: 238-250.
131. Tuma, P.L., and Hubbard, A.L. 2003. Transcytosis: crossing cellular barriers. Physiol. Rev. 83: 871-932.
132. Uittenbogaard, A., Ying, Y., and Smart, E.J. 1998. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J. Biol. Chem. 273: 6525-6532.
133. van Deurs, B., Roepstorff, K., Hommelgaard, A.M., and Sandvig, K. 2003. Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol. 13: 92-100.
134. Volonte, D., Galbiati, F., and Lisanti, M.P. 1999. Visualization of caveolin-1, a caveolar marker protein, in living cells using green fluorescent protein (GFP) chimeras. The subcellular distribution of caveolin-1 is modulated by cell-cell contact. FEBS Lett. 445: 431-439.
135. Volonte, D., Galbiati, F., Pestell, R.G., and Lisanti, M.P. 2001. Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr(14)) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J. Biol. Chem. 276: 8094-8103.
136. Volonte, D., Zhang, K., Lisanti, M.P., and Galbiati, F. 2002. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol. Biol. Cell, 13: 2502-2517.
137. Wary, K.K., Mariotti, A., Zurzolo, C., and Giancotti, F.G. 1998. A requirement for caveolin-1 and associated kinase fyn in integrin signaling and anchorage-dependent growth. Cell, 94: 625-634.
138. Wiechen, K., Diatchenko, L., Agoulnik, A., Scharff, K.M., Schober, H., Arlt, K., Zhumabayeva, B., Siebert, P.D., Dietel, M., Schafer, R., and Sers, C. 2001a. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159: 1635-1643.
139. Wiechen, K., Sers, C., Agoulnik, A., Arlt, K., Dietel, M., Schlag, P.M., and Schneider, U. 2001b. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am. J. Pathol. 158: 833-839.
140. Wikman, H., Kettunen, E., Seppanen, J.K., Karjalainen, A., Hollmen, J., Anttila, S., and Knuutila, S. 2002. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene, 21: 5804-5813.
141. Yamabhai, M., and Anderson, R.G. 2002. Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts. J. Biol. Chem. 277: 24 843 - 24 846.
142. Yamada, E. 1955. The fine structures of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1: 445-458.
143. Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M.P., Myers, M.G., Jr., and Ishikawa, Y. 1998. Caveolin is an activator of insulin receptor signaling. J. Biol. Chem. 273: 26 962 - 26 968.
144. Yang, G., Truong, L.D., Timme, T.L., Ren, C., Wheeler, T.M., Park, S.H., Nasu, Y., Bangma, C.H., Kattan, M.W., Scardino, P.T., and Thompson, T.C. 1998. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4: 1873-1880.
145. Yang, G., Truong, L.D., Wheeler, T.M., and Thompson, T.C. 1999. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 59: 5719-5723.
146. Zhang, W., Razani, B., Altschuler, Y., Bouzahzah, B., Mostov, K.E., Pestell, R.G., and Lisanti, M.P. 2000. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J. Biol. Chem. 275: 20 717 - 20 725.